Paul Hartmann

Paul Hartmann EBIT per Share

The EBIT per Share of Paul Hartmann (PHH2.F) as of Nov 3, 2026 is 27.45 EUR. In the previous year, EBIT per Share was 32.15 EUR — a change of -14.60% (lower).

EBIT per Share

27.45EUR

YoY

-14.60%

Last updated:

EBIT per Share of Paul Hartmann is 2025 27.45 EUR. EBIT per Share of Paul Hartmann was 2024 32.15 EUR. It decreases by -14.60% lower compared to the previous year.

The Paul Hartmann EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
57.56 EUR
Jan 1, 2019
19.99 EUR
Jan 1, 2020
38.32 EUR
Jan 1, 2021
31.94 EUR
Jan 1, 2022
8.69 EUR
Jan 1, 2023
9.55 EUR
Jan 1, 2024
32.15 EUR
Jan 1, 2025
27.45 EUR
The Paul Hartmann EBIT per Share history
YEAREBIT per ShareYoY
27.45EUR-14.60%
32.15EUR+236.78%
9.55EUR+9.84%
8.69EUR-72.80%
31.94EUR-16.64%
38.32EUR+91.71%
19.99EUR-65.28%
57.56EUR+77.79%
32.38EUR+14.05%
28.39EUR-17.36%
34.35EUR-7.78%
37.25EUR+19.22%
31.25EUR+22.80%
25.44EUR-14.39%
29.72EUR+1.33%
29.33EUR+13.06%
25.94EUR+71.38%
15.14EUR-18.05%
18.47EUR+67.09%
11.06EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Paul Hartmann Stock analysis

What does Paul Hartmann do? Paul Hartmann AG is a company that operates in the healthcare industry and operates worldwide. The company was founded in 1818 by Paul Hartmann in Heidenheim an der Brenz as a hand weaving mill. The company quickly expanded and began producing medical dressings in the 1920s. Since then, the company has evolved into a leading provider of medical products and services. Paul Hartmann's business model is based on the idea of offering a comprehensive range of medical products and services. The products include medical consumables, wound and incontinence products, as well as disinfectants and cleaning agents. In addition, the company also offers medical services such as consulting, training, and support. Paul Hartmann AG operates in various segments. One of the most important segments is "wound care," in which the company offers a wide range of dressings and wound care products. The incontinence care segment includes products such as disposable diapers and incontinence briefs. In addition, the company also offers a range of personal care products that focus on the care of the elderly. The company has a strong focus on research and development. It invests in innovative technologies and is constantly seeking new products to improve the lives of patients and caregivers. Furthermore, the company is also committed to developing environmentally friendly products that focus on sustainability and resource conservation. A well-known product of Paul Hartmann AG is the "Dermaplast" brand, which offers medical dressings. The products are known for their good quality and craftsmanship and meet the highest medical standards. The "MoliCare" brand, a brand for incontinence care, is also well-known, offering high-quality products for intensive care for affected individuals. Overall, Paul Hartmann AG is headquartered in Heidenheim an der Brenz, but operates worldwide and employs over 11,600 people. The company is committed to offering a comprehensive range of medical products and services to improve the lives of patients and caregivers. The company has a long history and a strong focus on research and development, making it an important player in the healthcare industry. Paul Hartmann is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Paul Hartmann stock

EBIT per Share of Paul Hartmann is 27.45 EUR in 2025.

EBIT per Share of Paul Hartmann changed from 32.15 EUR to 27.45 EUR, representing a -14.60% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Paul Hartmann since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Paul Hartmann

All Key Metrics — Paul Hartmann